top of page

Press Releases

June 19, 2024

NexEos Bio Announces Pipeline Expansion

May 1, 2023

NexEos Bio Names Dawn Rubel as President, Research and Development

March 28, 2023

Pivot Center: University of Utah researcher, Dr. Gerald Gleich of NexEos Bio recognized for decades-long career studying eosinophils

April 10, 2020

FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agent as a Diagnostic for the Management of Eosinophilic Esophagitis

August 9, 2019

NexEos licenses novel University of Utah imaging tech for diagnosing eosinophil-related inflammation

bottom of page